每年研究成果
研究成果 1995 2020
2019
2
引文
(Scopus)
Tolerability of rifapentine-based regimens in latent tuberculosis infection treatment in the elderly
Chan, P. C., Lee, P. H., Lu, M. J., Huang, Y. C., Feng, T. Y., Chen, W. W., Lee, C. C., Huang, Y. F. & Chiang, C. Y., 三月 1 2019, 於 : The European respiratory journal. 53, 3研究成果: 雜誌貢獻 › 快報
開啟存取
rifapentine
Latent Tuberculosis
Therapeutics
2017
2
引文
(Scopus)
Gefitinib or erlotinib for previously treated lung adenocarcinoma: Which is superior?
Chang, C. H., Lee, C. H. & Wang, J. Y., 四月 20 2017, 於 : Journal of Clinical Oncology. 35, 12, p. 1374 1 p.研究成果: 雜誌貢獻 › 快報
Erlotinib Hydrochloride
Adenocarcinoma of lung
gefitinib
10
引文
(Scopus)
Shortened multidrug-resistant tuberculosis regimens overcome low-level fluoroquinolone resistance
Van Deun, A. & Chiang, C. Y., 六月 1 2017, 於 : European Respiratory Journal. 49, 6, 1700223.研究成果: 雜誌貢獻 › 快報
Multidrug-Resistant Tuberculosis
Fluoroquinolones
5
引文
(Scopus)
Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan
Lee, M. R., Ho, C. M., Lee, C. H., Lee, M. C., Chang, L. Y., Yu, K. L., Ko, J. C., Wang, J. Y., Wang, J. T. & Lee, L. N., 八月 1 2017, 於 : The European respiratory journal. 50, 2研究成果: 雜誌貢獻 › 快報
Contact Tracing
Cost of Illness
Preschool Children
Taiwan
Proportional Hazards Models
2015
2
引文
(Scopus)
Coinfection of Pneumocystis jiroveci pneumonia and pulmonary tuberculosis in a non-HIV-infected patient
Suk, C. W., Bai, K-J., Yu, M-C. & Hu, T. Y., 十二月 1 2015, 於 : Journal of Microbiology, Immunology and Infection. 48, 6, p. 711-712 2 p.研究成果: 雜誌貢獻 › 快報
AIDS-Related Opportunistic Infections
Pneumocystis carinii
Pneumocystis Pneumonia
Coinfection
Pulmonary Tuberculosis
2009
Weekly cetuximab and gemcitabine plus cisplatin as salvage therapy for unresectable non-small cell lung cancer
Tai, C. J., Hsu, C. H., Wang, F. J., Chau, W. K., Chung, C. L. & Hsieh, C. C., 十一月 2009, 於 : Onkologie. 32, 11, p. 685-686 2 p.研究成果: 雜誌貢獻 › 快報